News

The Hemabate® injection, 250 mcg/mL brand had U.S. sales of approximately $55 million MAT for the most recent twelve months ending in April 2019 according to IQVIA Health*. Dr. Reddy’s ...
Even with algorithms available, dosing for Mircera appears to vary widely among ... an arbitrary single number (between 220 to 225 mcg per dose), not based on initial dose calculations or body ...
FRANKFURT (Reuters) - Kidney dialysis provider Fresenius Medical Care (FMC) expects more than 70 percent of eligible U.S. patients to have switched to cheaper alternative anemia treatment Mircera ...
The Hemabate® injection, 250 mcg/mL brand had U.S. sales of approximately $55 million MAT for the most recent twelve months ending in April 2019 according to IQVIA Health*. Dr. Reddy’s ...